NO993180L - N-(pyridinylamino)isoindoler og beslektede forbindelser - Google Patents
N-(pyridinylamino)isoindoler og beslektede forbindelserInfo
- Publication number
- NO993180L NO993180L NO993180A NO993180A NO993180L NO 993180 L NO993180 L NO 993180L NO 993180 A NO993180 A NO 993180A NO 993180 A NO993180 A NO 993180A NO 993180 L NO993180 L NO 993180L
- Authority
- NO
- Norway
- Prior art keywords
- pyridinylamino
- related compounds
- isoindoles
- intermediates
- isoindolines
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- -1 N- (pyridinylamino) isoindoles Chemical class 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000007074 memory dysfunction Effects 0.000 abstract 1
- FRDNVRYBEXCNBP-UHFFFAOYSA-N n-pyridin-2-yl-1,3-dihydroisoindol-2-amine Chemical class C1C2=CC=CC=C2CN1NC1=CC=CC=N1 FRDNVRYBEXCNBP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77430896A | 1996-12-27 | 1996-12-27 | |
| US08/959,789 US6004977A (en) | 1996-12-27 | 1997-10-29 | N-(pyridinylamino) isoindolines and related compounds |
| PCT/US1997/020591 WO1998029407A2 (en) | 1996-12-27 | 1997-11-13 | N-(pyridinylamino)isoindolines for treating alzheimer's and depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993180D0 NO993180D0 (no) | 1999-06-25 |
| NO993180L true NO993180L (no) | 1999-08-26 |
Family
ID=27118867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993180A NO993180L (no) | 1996-12-27 | 1999-06-25 | N-(pyridinylamino)isoindoler og beslektede forbindelser |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0950056B1 (pt) |
| JP (1) | JP4256937B2 (pt) |
| KR (1) | KR20000062358A (pt) |
| AT (1) | ATE224387T1 (pt) |
| AU (1) | AU720466B2 (pt) |
| BR (1) | BR9714189A (pt) |
| CA (1) | CA2276203C (pt) |
| DE (1) | DE69715668T2 (pt) |
| DK (1) | DK0950056T3 (pt) |
| ES (1) | ES2179377T3 (pt) |
| HU (1) | HUP0000783A2 (pt) |
| IL (1) | IL130642A0 (pt) |
| NO (1) | NO993180L (pt) |
| PT (1) | PT950056E (pt) |
| WO (1) | WO1998029407A2 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6772195B1 (en) | 1999-10-29 | 2004-08-03 | Electronic Arts, Inc. | Chat clusters for a virtual world application |
| EP1283199A4 (en) * | 2000-05-16 | 2003-12-17 | Takeda Chemical Industries Ltd | MELANIN CONCENTRATION HORMONE ANTAGONIST |
| KR20060009686A (ko) * | 2004-07-26 | 2006-02-01 | 엘지이노텍 주식회사 | 반도체 발광소자 및 그 제조방법 |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| EP2647376A1 (en) | 2007-01-22 | 2013-10-09 | Gtx, Inc. | Nuclear receptor binding agents |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE115143T1 (de) * | 1987-04-24 | 1994-12-15 | Hoechst Roussel Pharma | N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel. |
| ATE118002T1 (de) * | 1989-08-02 | 1995-02-15 | Hoechst Roussel Pharma | 2,3-dihydro-1-(pyridinylamino)-indole, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| US5102891A (en) * | 1990-07-23 | 1992-04-07 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
| US5177088A (en) * | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
| US5328920A (en) * | 1991-04-17 | 1994-07-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted (pyridinylamino)-indoles |
-
1997
- 1997-11-13 BR BR9714189-5A patent/BR9714189A/pt not_active IP Right Cessation
- 1997-11-13 CA CA002276203A patent/CA2276203C/en not_active Expired - Fee Related
- 1997-11-13 IL IL13064297A patent/IL130642A0/xx unknown
- 1997-11-13 DK DK97948250T patent/DK0950056T3/da active
- 1997-11-13 EP EP97948250A patent/EP0950056B1/en not_active Expired - Lifetime
- 1997-11-13 PT PT97948250T patent/PT950056E/pt unknown
- 1997-11-13 JP JP52999098A patent/JP4256937B2/ja not_active Expired - Fee Related
- 1997-11-13 AU AU54349/98A patent/AU720466B2/en not_active Ceased
- 1997-11-13 DE DE69715668T patent/DE69715668T2/de not_active Expired - Fee Related
- 1997-11-13 AT AT97948250T patent/ATE224387T1/de not_active IP Right Cessation
- 1997-11-13 WO PCT/US1997/020591 patent/WO1998029407A2/en active IP Right Grant
- 1997-11-13 KR KR1019997005846A patent/KR20000062358A/ko active IP Right Grant
- 1997-11-13 HU HU0000783A patent/HUP0000783A2/hu unknown
- 1997-11-13 ES ES97948250T patent/ES2179377T3/es not_active Expired - Lifetime
-
1999
- 1999-06-25 NO NO993180A patent/NO993180L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0950056T3 (da) | 2003-01-27 |
| IL130642A0 (en) | 2000-06-01 |
| WO1998029407A2 (en) | 1998-07-09 |
| ES2179377T3 (es) | 2003-01-16 |
| HUP0000783A2 (hu) | 2001-04-28 |
| PT950056E (pt) | 2002-12-31 |
| JP4256937B2 (ja) | 2009-04-22 |
| EP0950056B1 (en) | 2002-09-18 |
| AU5434998A (en) | 1998-07-31 |
| CA2276203C (en) | 2003-07-22 |
| EP0950056A2 (en) | 1999-10-20 |
| JP2001511119A (ja) | 2001-08-07 |
| DE69715668D1 (de) | 2002-10-24 |
| ATE224387T1 (de) | 2002-10-15 |
| WO1998029407A3 (en) | 1998-10-22 |
| CA2276203A1 (en) | 1998-07-09 |
| BR9714189A (pt) | 2000-02-29 |
| AU720466B2 (en) | 2000-06-01 |
| DE69715668T2 (de) | 2003-07-31 |
| NO993180D0 (no) | 1999-06-25 |
| KR20000062358A (ko) | 2000-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
| MY131298A (en) | 5-heteroyl indole derivatives | |
| NO911694L (no) | Mikroemulsjonsblanding til haarbehandling, fremgangsmaate for fremstilling og anvendelse derav. | |
| DK1149905T3 (da) | Fremgangsmåder og præparat til polypeptidteknologi | |
| NO20052755L (no) | Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmate for dens fremstilling og dens anvendelse. | |
| DK0729951T3 (da) | Naphthylforbindelser, mellemprodukter, præparater og fremgangsmåder | |
| TR200002480T2 (tr) | İzaşemi tedavisi için guanidin türevleri | |
| AU5799294A (en) | Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use | |
| DK0832065T3 (da) | Substituerede N-(indol-2-carbonyl)glycinamider og derivater som glycogenphosphorylaseinhibitorer | |
| TR200100366T2 (tr) | Aktif madde dağıtmaya mahsus bileşikler ve bileşimler. | |
| DK0906029T3 (da) | Isoflavonberiget sojaproteinprodukt og fremgangsmåde til fremstilling heraf | |
| TR199901057T2 (pt) | ||
| NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
| NO931040L (no) | Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav | |
| IS4907A (is) | Nýjar bensímídasólafleiður sem vinna gegn magasári, aðferðir til að útbúa þær og lyfjablöndur sem innihalda þær | |
| ZA976967B (en) | Device and process for separating magnetic materials from pharmaceutical preparations, their starting or intermediate products, as well as agents that are produced with the of said device. | |
| NO993180L (no) | N-(pyridinylamino)isoindoler og beslektede forbindelser | |
| NO993297D0 (no) | Fast dyrkningsmedium for mikroorganismer, fremgangsmÕte for fremstilling herav og anvendelse herav | |
| NO975682L (no) | Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler | |
| MX9603516A (es) | Derivados de oxima y su uso como pesticidas. | |
| NO903386L (no) | Fremgangsmaate for fremstilling av 4-(n-substituert amino)-2-butynyl-1-karbamater og -tiokarbamater og derivater derav. | |
| DK0907633T3 (da) | Nye syntetiske catecholderivater, fremgangsmåde til fremstilling og anvendelse deraf | |
| MX9302549A (es) | Proteina receptora especifica para la region csvt cg de la trombospondina y metodo para su purificacion y caracterizacion. | |
| ES2126279T3 (es) | Nuevos tetrapeptidos su obtencion y empleo. | |
| DK0806949T3 (da) | Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |